Search results
Analyst Report: Sanofi
Morningstar Research via Yahoo Finance· 10 hours agoSanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's ...
Sanofi Sales, Profit Beat Expectations
The Wall Street Journal· 4 days agoSanofi backed its full-year earnings guidance after it reported first-quarter profit ahead of consensus, with sales growth driven by continued strength...
Sanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buy By Investing.com
Investing.com· 4 days agoSanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buy
Sanofi Posts Strong Sales Growth With New Hemophilia Medicine
Bloomberg· 4 days agoHave a confidential tip for our reporters? Sanofi posted first-quarter revenue that exceeded...
Sanofi reportedly lining up banks for consumer products spinoff (NASDAQ:SNY)
Seeking Alpha· 6 days agoSanofi (SNY) is reportedly lining up banks for a potential spinoff of its consumer health products...
Sanofi Asks Banks to Pitch for $20 Billion OTC Spinoff
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- French drugmaker Sanofi has asked banks to pitch for roles on the separation of its...
Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
Zacks via Yahoo Finance· 4 days agoSanofi SNY reported first-quarter 2024 adjusted earnings of 96 cents per American depositary share,...
Sanofi to Pay $100 Million to Settle Zantac Cancer Lawsuits
Insurance Journal· 6 days agoSanofi will pay more than $100 million to settle about 4,000 lawsuits accusing the French drugmaker...
Sanofi wins in late-stage trial for blood disorder candidate (NASDAQ:SNY)
Seeking Alpha· 6 days agoSanofi's (SNY) oral therapy, rilzabrutinib, shows promise in a Phase 3 trial for an autoimmune blood...
Sanofi crosses Sjögren’s off $5B drug’s hit list after phase 2 data disappoint
FierceBiotech· 4 days agoSanofi is narrowing development of one of its 5 billion euro ($5.4 billion), “pipeline-in-a-product”...
